Pancreatic endocrine tumors (PETs) have long fascinated clinicians and investigators
despite their relative rarity. Their clinical presentation varies depending on whether the …

Pancreatic endocrine tumors (PETs) have long fascinated clini-cians, because some can
release biologically active hormones that cause distinct syndromes and provide important …

Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …

In patients with multiple endocrine neoplasia type 1 (MEN1), the most common functional
pancreatic endocrine tumor (PET) syndrome is Zollinger-Ellison syndrome (ZES). ZES has …

Clinicopathological Features [1, 9, 10] The WHO classification [10] subdivides gastrinomas,
similar to other gastroenteropancreatic neuroendocrine tumors (GEP-NETs), into three …

The assessment of fasting serum gastrin (FSG) is essential for the diagnosis and
management of patients with the Zollinger-Ellison syndrome (ZES). Although many studies …

Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

Objective To determine the role of surgery in patients with Zollinger-Ellison syndrome (ZES)
and multiple endocrine neoplasia type 1 (MEN1) with either limited or advanced pancreatic …

In two-thirds of patients with Zollinger-Ellison syndrome (ZES), fasting serum gastrin (FSG)
levels overlap with values seen in other conditions. In these patients, gastrin provocative …

Objective: To evaluate the outcome of an aggressive surgical approach for
duodenopancreatic neuroendocrine tumors (PETs) associated with multiple endocrine …